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Flow-mediated vasodilation is augmented in a
corkscrew collateral artery compared with that in a
native artery in patients with thromboangiitis
obliterans (Buerger disease)
Yuichi Fujii, MD,a Noritaka Fujimura, MD,a Shinsuke Mikami, MD,a Tatsuya Maruhashi, MD,a
Yasuki Kihara, MD, PhD,a Kazuaki Chayama, MD, PhD,b Kensuke Noma, MD, PhD,c and
Yukihito Higashi, MD, PhD,c,d Hiroshima, Japan
Background: A healthy endothelium maintains vascular tone and structure. The purpose of this study was to evaluate
endothelial function in corkscrew collateral arteries in Buerger disease.
Methods: We measured flow-mediated vasodilation (FMD) in corkscrew arteries in 26 patients with Buerger disease, in
control arteries in 26 healthy subjects, and in native arteries in 16 patients with Buerger disease.
Results: Hyperemic flow was lower in corkscrew arteries than in native arteries in patients with Buerger disease and in
control arteries in healthy subjects. There was no significant difference between hyperemic flow in patients with Buerger
disease in whom measurements were performed in native arteries and that in healthy subjects. FMD was lower in
corkscrew arteries and native arteries in patients with Buerger disease than in control arteries in healthy subjects. There
was no significant difference between FMD in corkscrew arteries in patients with Buerger disease and in that in native
arteries. The ratio of FMD to hyperemic flow was significantly smaller in native arteries in patients with Buerger disease
than in corkscrew arteries and in control arteries in healthy subjects (5.5  6.2 vs 8.8  8.9 and 9.6  7.6 mL/min,
P < .001, respectively). There was no significant difference in the ratio of FMD to hyperemic flow between corkscrew
arteries in Buerger disease and control arteries in healthy subjects. Nitroglycerin-induced vasodilation was similar in all
leg arteries.
Conclusions: Endothelial function of a corkscrew collateral artery in patients with Buerger disease is maintained, while
endothelial function is impaired in a native artery in Buerger disease. ( J Vasc Surg 2011;54:1689-97.)
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lThromboangiitis obliterans (Buerger disease) is a seg-
mental inflammatory obliterative nonatherosclerotic dis-
ease of small- and medium-sized distal arteries.1,2 The
prevalence of Buerger disease is greater in Asia and Eastern
Europe than in North America and Western Europe.3-5
Although it is postulated that alteration of autoimmune
response contributes to the pathogenesis of Buerger dis-
ease,6-8 the etiology of Buerger disease remains unclear.
Buerger disease is closely related to exposure to heavy
tobacco smoking in relatively young men.9,10 Patients with
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doi:10.1016/j.jvs.2011.05.095uerger disease have lower quality of life because of inter-
ittent claudication, rest pain, ulcers, and several episodes
f lower extremity superficial thrombophlebitis. Recently,
e have shown that existence of large corkscrew collateral
rteries is a predictor of the prevention of ischemic ulcer
nd gangrene in patients with Buerger disease.11 Cork-
crew collaterals can be visualized as color Doppler flows.12
he diameter and pulsed Doppler velocity of some cork-
crew collateral arteries can be measured by duplex ultra-
onography.
The vascular endothelium is involved in the release of
arious vasodilators, including nitric oxide (NO), prostacy-
lin, and endothelium-derived hyperpolarizing factor, as
ell as the release of vasoconstrictors.13,14 NO plays an
mportant role in the regulation of vascular tone, inhibition
f platelet aggregation, and suppression of smooth muscle
ell proliferation.15,16 Endothelial dysfunction is an early
eature of atherosclerosis and vascular diseases in humans.17
n addition, endothelial function is an independent predic-
or of cardiovascular morbidity and mortality.18,19 There-
ore, it is clinically important to estimate the degree of
ndothelial function. Cardiovascular diseases, including hy-
ertension,20-22 dyslipidemia,23 diabetes mellitus24 and
oronary artery diseases,25,26 are associated with endothe-
ial dysfunction in the forearm, coronary, and renal vascu-
atures. Buerger disease is also associated with endothelial
ysfunction.27,28 However, there is no information on
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December 20111690 Fujii et alvascular function in native leg arteries and corkscrew col-
lateral arteries per se in patients with Buerger disease.
Therefore, we assessed vascular function in a leg artery
using ultrasonography in patients with Buerger disease and
age- and sex-matched healthy subjects.
METHODS
Patients. Twenty-six patients with Buerger disease
(23 men and 3 women; age range, 26-50 years; mean age,
43  11 years) who had corkscrew arteries in which flow-
mediated vasodilation (FMD) was able to be measured
(artery diameter2 mm), 16 patients with Buerger disease
(15 men and 1 woman; age range, 26-50 years; mean age,
43 11 years) who had no corkscrew arteries or had small
corkscrew arteries (artery diameter 1 mm) and 26 age-
and sex-matched normal subjects (23 men and 3 women;
age range, 26-50 years; mean age, 43  11 years) were
enrolled in this study. Patients with Buerger disease had no
history of hypertension, diabetes mellitus, dyslipidemia,
cardiovascular disease, or other diseases. Buerger disease
was diagnosed by the previously reported criteria,29 includ-
ing results of physical examinations, clinical symptoms,
angiographic findings, and results of arterial duplex scan-
ning. To rule out other vasculitis and hypercoagulable
states, rheumatoid factor, lupus anticoagulants, and sero-
logic investigations were evaluated. Exclusion criteria were
critical limb ischemia, foot ulcer, major and minor ampu-
tation, surgical interventions such as bypass grafting, skin
grafting, and sympathectomy, and exercise training. The
study protocol was approved by the Ethics Committee of
Hiroshima University Graduate School of Biomedical Sci-
ences. Written informed consent for participation in the
study was obtained from all subjects.
Study protocol. We measured vascular responses to
reactive hyperemia and sublingual nitroglycerine in native
tibial arteries without stenosis and in occluded arteries or
corkscrew collateral arteries at the site of the tibial lesion in
all subjects. Subjects fasted the previous night for at least 12
hours. The study began at 8:30 AM. The subjects were kept
in the prone position in a quiet, dark, air-conditioned room
(constant temperature of 22° to 25°C) throughout the
study. A 23-gauge polyethylene catheter was inserted into
the left deep antecubital vein to obtain blood samples.
Thirty minutes after maintaining the prone position, basal
tibial artery diameter was measured. Then, FMD and nitro-
glycerin-induced vasodilation were measured. These stud-
ies were carried out in a randomized fashion. Each study
proceeded after tibial artery diameter had returned to base-
line.
Vascular function of both the corkscrew collateral ar-
tery and native tibial artery in the same patient were assessed
in nine of the 26 patients with Buerger disease. Vascular
function of the native tibial artery was assessed at the
opposite side that had a corkscrew collateral artery.
Digital subtraction angiography (DSA). All of the
subjects underwent intra-arterial DSA in the course of
examination for diagnosis of Buerger disease. Conventional
DSA was performed with a 4F pigtail catheter (Terumo, bokyo, Japan) by usingDSA units (Siemens-AsahiMedical,
okyo, Japan). The catheter tip was positioned at common
liac arteries and multiple images that encompassed the
highs, knees, and crural were acquired. At each station, 20
L of iopromidum was injected at a rate of 10 mL/s. The
xistence of corkscrew collaterals was carefully confirmed
y angiographic findings in all patients. We classified col-
ateral arteries by artery amplitude and corkscrew formation
attern into four categories: type I, artery diameter of 2
m; type II, artery diameter of1.5 mm and2mm; type
II, artery diameter of1 mm and1.5 mm; and type IV,
rtery diameter of 1 mm, as previously described.11
Duplex ultrasonography. Lower extremity arterial
uplex scanning was performed in all of the 26 patients
ith Buerger disease and 26 healthy subjects. All of the
uplex ultrasonography scans were performed by ultra-
onograhic specialists who were aware of the angiographic
ndings of DSA. The ultrasound unit Aloka-7 (Aloka Co,
okyo, Japan) equipped with a linear, phased-array high-
requency (13-MHz) transducer was used for scanning
eripheral arteries. Arterial duplex scanning was started at
he femoral artery in the recumbent position. The trans-
ucer was placed at the inguinal ligament and then moved
istally to the knee, following the course of the superficial
rteries. Then, the transducer was repositioned below the
nee and moved distally to the ankle, following the course
f anterior tibia arteries. The popliteal arteries, posterior
ibial arteries, and peroneal arteries were examined in the
rone position. Although most of the arterial segments
ere accessible, some arterial segments in the calf could not
e evaluated because of the thickness of calf muscle. Arter-
es were scanned with the probe positioned parallel to
imbs, since most of the collateral arteries ran parallel to the
riginal arteries. A diagnosis of occlusion of a peripheral
rtery was made on the basis of lack of flow signal at the
sual place of original arteries. Collateral arteries were
dentified to be presence of arterial flow signals in unusual
laces other than original arteries. Color gain was adjusted
ndividually for each collateral to optimize visualization of
he collaterals. Corkscrew collateral arteries were showed as
lternate red and blue color-Doppler flow signals. We
elected arteries with a diameter of 2 mm for measure-
ent of FMD in accordance with angiographic findings
Fig 1).
Measurement of vascular function. A high-resolution
inear artery transducer was coupled to computer-assisted
nalysis software (Aloka-7, Aloka Co) that used an auto-
ated edge detection system for measurement of artery
iameter. A blood pressure cuff was placed around the
high. The target artery was scanned longitudinally. When
he clearest B-mode image of the intimal interfaces between
he lumen and vessel wall was obtained, the transducer was
eld at the same point throughout the scan by a special
robe holder (MP-PH0001; Aloka Co) to ensure consis-
ency of the image. A baseline image is acquired, and blood
ow is estimated by time-averaging the pulsed Doppler
elocity signal obtained from a sample volume. Then, the
lood pressure cuff was inflated to 50 mm Hg above
i
m
w
i
d
r
w
f
d
fl
(
m
m
p
b
o
g
d
s
i
r.
JOURNAL OF VASCULAR SURGERY
Volume 54, Number 6 Fujii et al 1691systolic pressure for 5 minutes. Depth and gain setting were
set to optimize the images of the arterial lumen wall inter-
face. When the tracking gate was placed on the intima, the
artery diameter was automatically tracked and the wave-
form of diameter changes over the cardiac cycle was dis-
played in real-time using the FMD mode of the tracking
system. This allowed the ultrasound images to be opti-
mized at the start of the scan and the transducer position to
be adjusted immediately for optimal tracking performance
throughout the scan. A Doppler signal is recorded from
the center of the vessel with an automated set-of-range
gate. We adjusted sample volume to be as wide as possible
in the vessel wall in every native artery and corkscrew
collateral artery. Pulsed Doppler flow was assessed at base-
line and during peak hyperemic flow, which was confirmed
to occur within 15 seconds after cuff deflation. Blood flow
velocity was calculated from the color Doppler data and was
displayed as a waveform in real-time. The baseline longitu-
dinal image of the artery was acquired for 30 seconds and
then the blood pressure cuff was inflated to 50 mm Hg
Fig 1. Digital subtraction angiography (left) and ultras
diameter and corkscrew collaterals of 2.1 mm in diameteabove systolic pressure for 5 minutes. The longitudinal rmage of the artery was recorded continuously until 5
inutes after cuff deflation. Pulsed Doppler velocity signals
ere obtained for 20 seconds at baseline and for 10 seconds
mmediately after cuff deflation. Changes in brachial artery
iameter were immediately expressed as percent change
elative to the vessel diameter before cuff inflation. FMD
as calculated as the percent change in peak vessel diameter
rom the baseline value. %FMD (peak diameter – baseline
iameter/baseline diameter) was used for analysis. Blood
ow was calculated as 3 time-averaged velocity integrals
cm)  cross-sectional area of artery (r2)  heart rate (per
inutes). Reactive hyperemia was calculated as the maxi-
um percentage increase in flow after cuff deflation com-
ared with baseline flow. After a 10-minute period to allow
aseline conditions of the artery to be reestablished, an-
ther baseline scan was performed. The response to nitro-
lycerine was used for assessment of endothelium-indepen-
ent vasodilation. After stored baseline resting images, a
ublingual nitroglycerine tablet (75 g) was given, and
mages of the artery were recorded for 5 minutes. The
raphy (right) show the native tibial artery of 2.2 mm inonogesponse of the artery diameter to nitroglycerine was ex-
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December 20111692 Fujii et alpressed as percent change relative to vessel diameter.
Nitroglycerin-induced vasodilation was automatically cal-
culated as the percent change in peak vessel diameter from
the baseline value: percent nitroglycerine (peak diameter –
baseline diameter/baseline diameter) was used for analysis.
Baseline fasting serum concentrations of total choles-
terol, high-density lipoprotein (HDL) cholesterol, low-
density lipoprotein (LDL) cholesterol, triglycerides, glu-
cose, insulin, electrolytes, C-reactive protein (CRP), and
malondialdehyde-modified low-density lipoprotein (MDA-
LDL) were obtained after a 30-minute rest period before
the study. The 24-hour urinary excretion of 8-hydroxy-2=-
deoxyguanosine (8-OHdG) was determined.
Analytical methods. Samples of venous blood were
placed in tubes containing sodium ethylenediamine tet-
raacetic acid (1 mg/mL) and in polystyrene tubes. The
ethylenediamine tetraacetic acid-containing tubes were
chilled promptly in an ice bath. Plasma was immediately
separated by centrifugation at 3100g for 10minutes at 4°C,
and serum was separated by centrifugation at 1000g for 10
minutes at room temperature. Samples were stored at
80°C until the time of assay. Serum concentrations of
total cholesterol, triglycerides, HDL cholesterol, LDL cho-
lesterol, glucose, and electrolytes were determined by rou-
tine chemical methods. Serum concentration of CRP was
measured by a CRP kit (Dade Behring, Deerfield, Ill). The
serum concentration of MDA-LDL was assayed by en-
zyme-linked immunosorbent assay (anti-MDA-modified
LDL antibody; SRL, Atsugi, Japan). The urinary excretion
of 8-OHdG also was assayed by enzyme-linked immu-
nosorbent assay using 8-OHdG kits (Nihon Yushi, Fuku-
Table I. Clinical characteristics of the normal control and
Norm
(n
Body mass index, kg/m2 22.
Systolic blood pressure, mm Hg 114.
Diastolic blood pressure, mm Hg 61.
Heart rate, bpm 65.
Total cholesterol, mmol/L 4.7
Triglycerides, mmol/L 1.1
High density lipoprotein cholesterol, mmol/L 1.3
Low density lipoprotein cholesterol, mmol/L 2.5
Glucose, nmol/dL 4.
Insulin, pmol/L 54.
C-reactive protein, mg/dL 0.0
MDA-LDL, U/L 56.
Urinary 8-OHdG, ng/mg Cr 9.
Fontaine classification, n
I
II
III
IV
Skin perfusion pressure, mm Hg 95.
Transcutaneous oxygen pressure, mm Hg 68.
Ankle-brachial pressure index 1.1
MDA-LDL, Malondialdehyde low density lipoprotein; 8-OHdG, 8-hydroxy
All results are presented as mean  SD.
aP  .05 vs normal.roi, Japan). nStatistical analysis. Data were presented as the
eans SD. All reported P values were two-tailed. Results
ere considered significant at P  .05. Multigroup com-
arisons of variables were carried out by one-way analysis of
ariance followed by the Bonferroni correction. Analysis
as completed using the software packages Stat View IV
SAS Institute, Cary, NC) or Super Analysis of Variance
Abacus Concepts, Berkley, Calif). Values of P  .05 were
onsidered significant.
ESULTS
Clinical characteristics. Baseline clinical characteris-
ics of the 26 patients with Buerger disease in whom
easurements were performed in a corkscrew artery, the 16
atients with Buerger disease in whom measurements were
erformed in a native artery, and the 26 normal control
ubjects are summarized in Table I. The serum concentra-
ion of CRP was higher in patients with Buerger disease
han in normal control subjects. There was no significant
ifference in the serum concentration of CRP between the
uerger disease native artery group and the Buerger disease
orkscrew collateral artery group. There were no significant
ifferences in the serum concentration of MDA-LDL and
rinary excretion of 8-OHdG, oxidative stress markers,
mong the three groups. Skin perfusion pressure and trans-
utaneous oxygen pressure were significantly lower in pa-
ients with Buerger disease than in normal controls and
ere similar in the Buerger native artery group and Buerger
orkscrew collateral artery group. Ankle-brachial pressure
ndex was significantly lower in patients with Buerger dis-
ase than in normal controls and was similar in the Buerger
ger groups
ntrol
)
Buerger native
(n  16)
Buerger corkscrew
(n  26)
.1 22.5  3.3 23.1  3.5
.7 112.2  10.1 112.6  11.1
.5 62.2  6.3 63.5  6.3
.8 68.3  11.9 69.2  10.6
.63 4.82  0.67 4.76  0.71
.67 1.17  0.77 1.06  0.62
.15 1.32  0.13 1.34  0.23
.27 2.55  0.41 2.52  0.53
.2 4.7  0.2 4.7  0.2
1.5 55.9  12.3 53.8  13.1
.07 2.11  1.94a 2.15  2.16a
8.2 59.3  20.1 58.4  21.2
.1 9.5  2.8 9.9  3.2
4 6
7 10
4 8
1 2
5.9 29.5  12.1a 30.9  13.5a
2.7 35.8  17.2a 38.3  16.5a
.11 0.72  0.16a 0.74  0.17a
oxyguanosine.Buer
al co
 26
3  3
7  9
7  6
2  9
4  0
4  0
6  0
6  0
6  0
5  1
8  0
3  1
6  3
–
–
–
–
3  1
5  1
2  0
-2=-deative artery group and Buerger corkscrew collateral artery
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Volume 54, Number 6 Fujii et al 1693group. There were no significant differences in other pa-
rameters between the normal control group and the
Buerger groups.
Vascular function. Baseline artery diameter, baseline
flow, hyperemic flow, percent change in hyperemic flow,
FMD, and nitroglycerin-induced vasodilation are shown in
Table II. Fig 2 shows representative data for baseline artery
diameter, baseline flow, peak vasodilation after hyperemic
stimuli, and hyperemic flow in normal healthy subjects,
Buerger disease patients with native artery, and Buerger
disease patients with corkscrew collateral artery. Hyperemic
flow and percent change in hyperemic flow were signifi-
cantly lower in corkscrew arteries than in native arteries
in patients with Buerger disease and in control arteries in
healthy subjects. There were no significant differences in
hyperemic flow and percent change in hyperemic flow
between patients with Buerger disease in whom measure-
ments were performed in native arteries and healthy sub-
jects. FMD was lower in corkscrew arteries and native
arteries in patients with Buerger disease than in control
arteries in healthy subjects. There was no significant differ-
ence in FMD between corkscrew arteries and native arteries
in patients with Buerger disease. The ratios of FMD to
hyperemic flowwere similar in corkscrew arteries in patients
with Buerger disease and in control arteries in healthy
subjects (8.8  8.9 mL/min vs 9.6  7.6 mL/min, P 
.76), while the ratio of FMD to hyperemic flow was signif-
icantly smaller in native arteries in patients with Buerger
disease than in corkscrew arteries and in control arteries in
healthy subjects (5.5  6.2 mL/min vs 8.8  8.9 and
9.6  7.6 mL/min, P  .001, respectively, Fig 3). There
were no significant differences in other vascular functions
among the three groups. In addition, we confirmed
vascular function in the native artery and corkscrew
collateral artery in the same patients (n  9, Table III).
Hyperemic flow and percent change in hyperemic flow
were significantly lower in corkscrew arteries than in
native arteries. The ratio of FMD to hyperemic flow was
significantly greater in corkscrew arteries than in native
arteries in the same patients (11.1  9.1 mL/min vs 6.5 
7.9 mL/min, P  .001, Fig 4). There were no significant
differences in other vascular functions between corkscrew
arteries and native arteries. Nitroglycerin-induced vasodila-
Table II. Vascular function of the normal control and Bu
Normal co
(n  26
Baseline artery diameter, mm 2.3  0
Baseline flow, mL/min 52  5
Hyperemic flow, mL/min 164  1
Change in hyperemic flow, % 377  3
Flow-mediated vasodilation, % 8.0  3
Nitroglycerin-induced vasodilation, % 11.4  5
All results are presented as mean  SD.
aP  .05 vs normal.
bP  .05 vs Buerger native.tion was similar in all leg arteries. tISCUSSION
We demonstrated, for the first time, endothelial func-
ion in leg circulation in Buerger disease. Endothelial func-
ion in leg circulation was similar in corkscrew collateral
rteries of Buerger disease and control artery of healthy
ubjects. Endothelial function in native leg arteries was
mpaired in patients with Buerger disease.
In the present study, the ratio of FMD to hyperemic
ow was significantly smaller in native arteries in patients
ith Buerger disease than in corkscrew collateral arter-
es and in control arteries in healthy subjects, whereas
itroglycerin-induced vasodilation was similar in the three
roups. These findings suggest that the vascular endothe-
ium, but not smooth muscle cells, is selectively impaired in
ative arteries in patients with Buerger disease.
Buerger disease is associated with endothelial dysfunc-
ion assessed by FMD and by vascular response to acetyl-
holine in forearm circulation.27,28 In the present study
lso, FMD in native leg arteries in patients with Buerger
isease was impaired compared with that in healthy sub-
ects. The precise mechanism of endothelial dysfunction in
atients with Buerger disease is unclear. Patients with
uerger disease had no classic cardiovascular risk factors,
hich influence endothelial function. In addition, other
onfounding factors for endothelial function, such as oxi-
ative stress markers, other than an inflammation marker,
ere similar in patients with Buerger disease and healthy
ontrols. Systemic inflammation may contribute to endo-
helial dysfunction through a decrease in NO bioavailabil-
ty, a decrease in NO production and/or an increase in NO
nactivation. Production of proinflammatory cytokines re-
ults in activation of endothelial cells under the condition of
hronic inflammation, leading to excessive induction of
dhesion molecules, cytokines, growth factors, and vaso-
onstrictors.30,31 In addition, proinflammatory cytokines
uch as tumor necrotic factor- and interleukin-6 down-
egulate the expression of endothelial NO synthase
eNOS).32 Tumor necrotic factor- alone decreases the
alf-life of eNOS mRNA in human endothelial cells.33
dministration of proinflammatory cytokines attenuates
ndothelium-dependent vasodilation in vivo.34 Interest-
ngly, CRP also directly decreased eNOS mRNA and pro-
groups
Buerger native
(n  16)
Buerger corkscrew
(n  26)
2.4  0.6 2.2  0.7
52  31 56  49
145  109 98  90a
206  189 80  82a,b
5.5  2.7a 5.8  3.2a
10.6  4.9 10.2  5.9erger
ntrol
)
.4
7
08
48
.2
.4ein levels and enzymatic activity in human aortic endothe-
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December 20111694 Fujii et allial cells.35 Endothelial dysfunction promotes inflammation
of the vascular wall, leading to a vicious circle between
endothelial dysfunction and inflammation. Recently, we
have reported that chronic infection with Helicobacter py-
Fig 2. Representative flow-mediated vasodilation (FMD) and hy-
peremic flow in the tibial artery in normal control subject and in
the native tibial artery or corkscrew collateral artery at the site of
the tibial lesion in patients with Buerger disease.lori impairs endothelium-dependent vasodilation in healthy hale subjects and that periodontitis is associated with en-
othelial dysfunction in subjects without cardiovascular
isk factors as well as hypertensive patients through a de-
rease in NO bioavailability.36,37 These findings suggest
hat several pathways of proinflammatory factors in Buerger
isease may contribute to downregulation of the expression
f eNOS and decrease in enzymatic activity, resulting in
ecrease in NO production.
Oxidative stress plays an important role in the patho-
enesis and development of cardiovascular diseases.38,39 In
ddition, it is well known that a balance between ambient
evels of superoxide and NO release plays a critical role in
he maintenance of normal endothelial function. Reactive
xygen species, including hydroxy radicals, directly scav-
nge NO and produce toxic peroxynitrite.40 Recently, we
ig 3. Bar graphs show the ratio of flow-mediated vasodilation
FMD) to hyperemic flow in control arteries in healthy subjects and
n native arteries and corkscrew arteries in patients with Buerger
isease.
able III. Vascular function of corkscrew artery in the
ame patients
Buerger (n  9)
Native Corkscrew
aseline artery diameter, mm 2.4  0.9 2.1  0.5
aseline flow, mL/min 42  28 40  14
yperemic flow, mL/min 121  123 77  60a
hange in hyperemic flow, % 220  208 90  115a
low-mediated vasodilation, % 5.2  3.5 5.6  3.0
itroglycerin-induced vasodilation, % 10.8  5.6 9.5  6.7
ll results are presented as mean  SD.
P  .05 vs native.ave shown that inactivation of the renin-angiotensin
e
c
t
v
y
t
t
t
o
s
p
B
i
u
w
u
c
c
a
D
l
i
e
r
t
B
a
i
e
d
t
r
s
f
h
a
a
k
i
e
c
w
a
c
c
s
a
a
i
c
m
b
a

t
JOURNAL OF VASCULAR SURGERY
Volume 54, Number 6 Fujii et al 1695system, particularly angiotensin II, by successful renal an-
gioplasty decreases oxidative stress, resulting in improved
endothelium-dependent vasodilation in patients with reno-
vascular hypertension.41 These findings suggest that oxida-
tive stress may be involved in impaired NO-mediated vaso-
dilation in humans. Therefore, enhanced production of
reactive oxygen species and an attenuated antioxidant sys-
tem may contribute to endothelial dysfunction in patients
with Buerger disease through an inactivation of NO bio-
availability. However, in the present study, there were no
significant differences in oxidative stress markers, urinary
excretion of 8-OHdG and serum concentration of MDA-
LDL, between patients with Buerger disease and controls,
suggesting that oxidative stress is not enhanced in patients
with Buerger disease. It is unlikely that oxidative stress
contributes to endothelial dysfunction in patients with
Buerger disease.
Interestingly, the ratio of FMD to hyperemic flow was
significantly smaller in native arteries in patients with
Buerger disease than in corkscrew collateral arteries and in
control arteries in healthy subjects. There was no significant
difference in the ratio of FMD to hyperemic flow between
corkscrew collateral arteries in patients with Buerger disease
and control arteries in healthy subjects. These findings
suggest that endothelial function in a corkscrew collateral
artery is augmented compared with that in a native artery
and is restored to the level of endothelial function in
healthy controls, whereas the level of the inflammation
marker CRP was significantly higher in patients with
Buerger disease than in healthy controls.
Some possible mechanisms by which endothelial func-
tion is augmented in a corkscrew artery have been pos-
tulated. Corkscrew collateral arteries are developed by
Fig 4. Bar graphs show the ratio of flow-mediated vasodilation
(FMD) to hyperemic flow in native arteries and corkscrew arteries
in the same patients.severe stenosis and occlusion of native arteries as neo- tndovascularization. It is thought that endothelial cells in a
orkscrew collateral artery are young and have high func-
ional ability. Experimental studies, both in vitro and in
ivo, have clearly shown that eNOS activity is higher in
ounger endothelial cells and arteries than in older endo-
helial cells and arteries.42,43 Increased availability of endo-
helial cells in a corkscrew collateral artery may contribute
o activation of eNOS-NO pathways, leading to restoration
r maintenance of endothelial function.
We have recently shown that existence of a large cork-
crew collateral artery relates to clinical benefits, such as
revention of ischemic ulcer and gangrene in patients with
uerger disease.11 Augmentation of endothelial function
n a corkscrew collateral artery may, at least in part, contrib-
te to beneficial effects on clinical symptoms in patients
ith Buerger disease.
The present study has a number of limitations. First,
nfortunately, we were not able to measure FMD in small
orkscrew collateral arteries, since the resolution ability of a
onventional ultrasonography device does not enable visu-
lization of small arteries and measurements of pulsed
oppler velocity. Therefore, it is unclear whether endothe-
ial function in a small corkscrew collateral artery as well as
n a large corkscrew collateral artery is augmented. Inter-
stingly, development of large corkscrew collateral arteries
educes the prevalence of ischemic ulcers more than does
he development of small collateral arteries in patients with
uerger disease.11 Development of new modalities for
ccurate assessment of endothelial function in small arteries
s expected.We cannot deny the possibility that results from
ndothelial function in artery diameter of 1 mm are
ifferent in those in a large artery. Second, although endo-
helial function in a corkscrew collateral artery was clearly
estored, the number of subjects in the present study was
mall. We cannot deny the possibility of a type I or II error
rom our results. Third, we do not know the precise natural
istory of corkscrew collateral arteries per se and how long
ugmented endothelial function in a corkscrew collateral
rtery persists throughout the natural history of what is
nown to be a progressive disease. Future large-scale stud-
es are needed to confirm the role of augmentation of
ndothelial function in a corkscrew collateral artery in
linical symptoms and cardiovascular outcomes in patients
ith Buerger disease. Fourth, it is possible that Doppler
ngle correction in the corkscrew vessels is subject to error
aused by tortuosity. Meanwhile, in corkscrew arteries, we
an assess blood velocity without Doppler angle correction,
ince Doppler angle is close to zero. However, Doppler
ngle correction is frequently needed also in corkscrew
rteries, and the accuracy of measurement of flow velocity
n corkscrew arteries with Doppler angle correction is un-
lear. In general, native tibial artery in which FMD is
easured runs parallel to the skin surface. The ultrasound
eam bisects at right angles with blood flow. The accept-
ble Doppler angle in artery to assess blood velocity is
60°. Therefore, strict Doppler angle correction is needed
o assess blood velocity in the native tibial artery. Finally,
hemechanism of FMD, an index of endothelial function, is
11
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December 20111696 Fujii et ala release of nitric oxide from endothelial cells through an
increase in shear stress induced by increase in blood flow
(hyperemic flow) after cuff release. It is well known that
FMD is large in relation to increase in blood flow (hyper-
emic flow). Recently, even when there is no significant
difference in hyperemic flow between the groups, it has
been recommended that FMD should be normalized by
dividing the percentage of FMD by hyperemic flow.44
Since there were significant differences in hyperemic
flow among the groups in the present study, we normal-
ized FMD.
In conclusion, there is no information on endothelial
function in leg circulation in patients with Buerger disease.
We confirmed that in leg circulation also, Buerger disease is
associated with endothelial dysfunction. In the present
study, endothelium-dependent vasodilation was greater in
collateral arteries than in native arteries in patients with
Buerger disease and was restored to the level of that in
control leg arteries in healthy subjects. Although the clini-
cal significance of corkscrew collateral arteries is unclear,
augmentation of endothelial function in corkscrew collat-
erals may have various beneficial effects, including reduc-
tion in the prevalence of ischemic ulcers.
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